Nongwoobio Co. Ltd (054050) — Capital Reinvestment Ratio
Nongwoobio Co. Ltd (054050) has a Capital Reinvestment Ratio of 0.33x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩2.27 Billion) in capital expenditures (₩751.81 Million). Check 054050 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Nongwoobio Co. Ltd Capital Reinvestment Ratio (2009–2024)
This chart tracks Nongwoobio Co. Ltd's Capital Reinvestment Ratio across 16 annual periods. For the full cash flow conversion analysis, see how efficiently does Nongwoobio Co. Ltd generate cash.
Annual Capital Reinvestment Ratio for Nongwoobio Co. Ltd (2009–2024)
Year-by-year Capital Reinvestment Ratio for Nongwoobio Co. Ltd from 2009 to 2024. See 054050 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.48x | ₩18.98 Billion | ₩9.05 Billion | ▲ +41.2% |
| 2023 | 0.34x | ₩16.33 Billion | ₩5.51 Billion | ▼ -42.8% |
| 2022 | 0.59x | ₩9.70 Billion | ₩5.72 Billion | ▼ -39.4% |
| 2021 | 0.97x | ₩3.86 Billion | ₩3.76 Billion | ▲ +49.2% |
| 2020 | 0.65x | ₩5.99 Billion | ₩3.91 Billion | ▼ -97.6% |
| 2019 | 27.59x | ₩304.25 Million | ₩8.39 Billion | ▲ +14411.5% |
| 2018 | 0.19x | ₩26.80 Billion | ₩5.10 Billion | ▼ -74.5% |
| 2016 | 0.75x | ₩7.71 Billion | ₩5.75 Billion | ▲ +30.7% |
| 2015 | 0.57x | ₩1.78 Billion | ₩1.01 Billion | ▼ -79.5% |
| 2015 | 2.78x | ₩4.84 Billion | ₩13.47 Billion | ▲ +166.5% |
| 2014 | 1.04x | ₩13.21 Billion | ₩13.79 Billion | ▼ -16.7% |
| 2013 | 1.25x | ₩8.74 Billion | ₩10.94 Billion | ▼ -9.0% |
| 2012 | 1.38x | ₩5.91 Billion | ₩8.13 Billion | ▼ -12.9% |
| 2011 | 1.58x | ₩10.40 Billion | ₩16.42 Billion | ▲ +158.4% |
| 2010 | 0.61x | ₩6.96 Billion | ₩4.25 Billion | ▲ +176.3% |
| 2009 | 0.22x | ₩10.77 Billion | ₩2.38 Billion | — |